AVL-292 is a potent and specific Brutons tyrosine kinase (Btk) inhibitor. Studies showed that AVL-292 used in combination with Carfilzomib (C183460) impacted the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity. Molec
Molecular Weight:
423.44
CAS Number:
[1202757-89-8]
* VAT and and shipping costs not included. Errors and price changes excepted